↓ Skip to main content

The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2014
Altmetric Badge

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
Published in
Neuropsychiatric Disease and Treatment, August 2014
DOI 10.2147/ndt.s68951
Pubmed ID
Authors

Robert L Findling, Lawrence D Ginsberg

Abstract

To assess the safety and effectiveness of open-label treatment with extended-release carbamazepine (ERC) in pediatric subjects suffering from bipolar I disorder.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 16%
Student > Doctoral Student 5 10%
Researcher 5 10%
Student > Postgraduate 5 10%
Other 3 6%
Other 8 16%
Unknown 15 31%
Readers by discipline Count As %
Medicine and Dentistry 15 31%
Psychology 12 24%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Social Sciences 1 2%
Neuroscience 1 2%
Other 1 2%
Unknown 16 33%